Young age under 60years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer

Authors:

Abstract
No abstract available
Funding Information
  • National Cancer Institute, NIH (P30 CA006927)

This publication has 42 references indexed in Scilit: